Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05585710 · ClinicalTrials.gov registry record · NA
Pulsed Lavage in Implant-Based Breast Reconstruction
A NA study of Breast Reconstruction, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 62
- Enrollment target
- 1
- Study location
NCT05585710: Recruiting NA study of Breast Reconstruction, sponsored by University of Alabama at Birmingham.
NCT05585710 is a NA study of Breast Reconstruction that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 62 participants, below the 390-participant average among 18 other Breast Reconstruction trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05585710, a NA study of Breast Reconstruction, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine if there is any benefit to using pulsed lavage to wash out the mastectomy pocket during breast reconstruction. Primary outcomes will include post-op complications including surgical site infection (SSI), hematoma, seroma, and implant failure.
Primary Outcome
unintended complications that occur post-surgically
Conditions Studied
Interventions
- OTHER Pulsed Lavage Washout
- PROCEDURE Implant-based breast reconstruction
- PROCEDURE Bilateral or unilateral mastectomy
- DEVICE Tissue expander
- OTHER Acellular dermal matrix
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2024-03-01 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT05585710 shows while recruiting
NCT05585710 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 390-participant average among 18 other Breast Reconstruction trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Breast Reconstruction appearing as the primary indexed condition, and to 5 interventions - of which Pulsed Lavage Washout is the first listed.
NCT05585710 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT05585710 about?
NCT05585710 is a clinical study titled "Pulsed Lavage in Implant-Based Breast Reconstruction". To determine if there is any benefit to using pulsed lavage to wash out the mastectomy pocket during breast reconstruction. Primary outcomes will include post-op complications including surgical site infection (SSI), hematoma, seroma, and implant failure.
What is the current status of trial NCT05585710?
This trial is currently recruiting. It is a NA study. The enrollment target is 62 participants. The study started on 2024-03-01. Estimated completion is 2026-08.
What conditions does trial NCT05585710 study?
This clinical trial studies the following conditions: Breast Reconstruction.
What interventions are being tested in trial NCT05585710?
The interventions under investigation include: Pulsed Lavage Washout (OTHER), Implant-based breast reconstruction (PROCEDURE), Bilateral or unilateral mastectomy (PROCEDURE), Tissue expander (DEVICE), Acellular dermal matrix (OTHER).
Who is sponsoring clinical trial NCT05585710?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05585710 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Reconstruction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05585710's enrollment target sits among peer trials
62 15th of 18 higher than 4 of 18 other Breast Reconstruction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Reconstruction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study on Pain After Breast Reconstruction
RECRUITING · NA
-
Melodi Matrix™ in Breast Reconstruction
RECRUITING · NA
-
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
RECRUITING · NA
-
Impact of Pectoral Versus Paravertebral Blocks on Pain and Physical Well-Being in Implant-Based Breast Reconstruction
RECRUITING · NA
-
SAVE Trial: SAfe Opioid Use Video Education
RECRUITING · NA
-
Acellular Dermal Matrix Investigation in Breast Reconstruction
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI